Stay updated with breaking news from Dr Reddys Labs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Dr Reddy's Labs Q4 Results: The revenue from operations rose 12% YoY to Rs 7,083 crore while they dipped 2% quarter-on-quarter (QoQ). The revenue missed ET Now poll estimate of Rs 7,237 crore.
Agarwal will also cease to be a member of the Management Council and Senior Management Personnel of the company and will continue to be available with till August 31, 2024.
State Bank of India was the second largest gainer in the Nifty 50 on Thursday and ended at new closing high. The stock has formed a Bullish Marubozu kind of candlestick pattern on the daily charts, with robust volumes.
As Q4FY24 earnings season begins, Motilal Oswal estimates Nifty earnings to grow 6% YoY. Among stocks, the brokerage expects 5 Nifty50 constituents to witness over 45 percent surge in their net profit on a year-on-year (YoY) basis in Q4FY24. Let's take a look at these stocks:
The earnings for the December quarter (Q3FY24) so far have been in line with estimates for the most part. 33 Nifty stocks have reported sales, EBITDA, and PAT growth of 6 percent, 15 percent, and 21 percent YoY versus estimates of 7 percent, 14 percent, and 20 percent, respectively.